MANKIND PHARMA
Quarterly Results Analysis [Mar2026]
MANKIND PHARMA Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹3,443 Cr | ₹3,567 Cr | ₹3,697 Cr | ₹3,570 Cr | ₹3,079 Cr | ₹3,199 Cr | ₹3,061 Cr | ₹2,868 Cr |
| Expenses | ₹2,513 Cr | ₹2,648 Cr | ₹2,776 Cr | ₹2,724 Cr | ₹2,396 Cr | ₹2,383 Cr | ₹2,214 Cr | ₹2,196 Cr |
| Operating Income | ₹930 Cr | ₹919 Cr | ₹921 Cr | ₹847 Cr | ₹683 Cr | ₹816 Cr | ₹847 Cr | ₹672 Cr |
| Other Income | ₹114 Cr | ₹73 Cr | ₹92 Cr | ₹80 Cr | ₹251 Cr | ₹77 Cr | ₹109 Cr | ₹99 Cr |
| Interest | ₹142 Cr | ₹157 Cr | ₹170 Cr | ₹171 Cr | ₹191 Cr | ₹221 Cr | ₹7 Cr | ₹11 Cr |
| Depreciation | ₹223 Cr | ₹223 Cr | ₹222 Cr | ₹219 Cr | ₹231 Cr | ₹187 Cr | ₹100 Cr | ₹103 Cr |
| Profit Before Tax | ₹656 Cr | ₹506 Cr | ₹622 Cr | ₹537 Cr | ₹513 Cr | ₹485 Cr | ₹849 Cr | ₹657 Cr |
| Profit After Tax | ₹556 Cr | ₹411 Cr | ₹518 Cr | ₹441 Cr | ₹427 Cr | ₹374 Cr | ₹659 Cr | ₹535 Cr |
| EPS | ₹13.43 | ₹9.90 | ₹12.39 | ₹10.62 | ₹10.20 | ₹9.22 | ₹16.31 | ₹13.39 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MANKIND PHARMA | -0.6% | 11% | -1.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -3.2% | 10.5% | 9.3% |
| DIVIS LABORATORIES | 0.8% | 9.5% | 4.2% |
| TORRENT PHARMACEUTICALS | 2% | 9.9% | 35.4% |
| CIPLA | -1.9% | 13.3% | -6% |
| DR REDDYS LABORATORIES | -1.8% | 7.4% | 8.2% |
| LUPIN | 1.2% | -1.2% | 12.7% |
| ZYDUS LIFESCIENCES | 4.8% | 11.8% | 13.7% |
| AUROBINDO PHARMA | -2.5% | 3.1% | 28.2% |
MANKIND PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -3.48 % |
| Y-o-Y | 11.81 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,443 Cr | -3.48 | |
| Dec2025 | ₹3,567 Cr | -3.52 | |
| Sep2025 | ₹3,697 Cr | 3.55 | |
| Jun2025 | ₹3,570 Cr | 15.94 | |
| Mar2025 | ₹3,079 Cr | -3.73 | |
| Dec2024 | ₹3,199 Cr | 4.49 | |
| Sep2024 | ₹3,061 Cr | 6.75 | |
| Jun2024 | ₹2,868 Cr | - | |
MANKIND PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 1.14 % |
| Y-o-Y | 36.11 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹930 Cr | 1.14 | |
| Dec2025 | ₹919 Cr | -0.21 | |
| Sep2025 | ₹921 Cr | 8.81 | |
| Jun2025 | ₹847 Cr | 23.94 | |
| Mar2025 | ₹683 Cr | -16.27 | |
| Dec2024 | ₹816 Cr | -3.68 | |
| Sep2024 | ₹847 Cr | 26.15 | |
| Jun2024 | ₹672 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 4.81 % |
| Y-o-Y | 21.72 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 27.01% | 4.81 | |
| Dec2025 | 25.77% | 3.41 | |
| Sep2025 | 24.92% | 5.06 | |
| Jun2025 | 23.72% | 6.89 | |
| Mar2025 | 22.19% | -13.01 | |
| Dec2024 | 25.51% | -7.81 | |
| Sep2024 | 27.67% | 18.15 | |
| Jun2024 | 23.42% | - | |
MANKIND PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 35.49 % |
| Y-o-Y | 30.41 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹556 Cr | 35.49 | |
| Dec2025 | ₹411 Cr | -20.70 | |
| Sep2025 | ₹518 Cr | 17.31 | |
| Jun2025 | ₹441 Cr | 3.46 | |
| Mar2025 | ₹427 Cr | 13.95 | |
| Dec2024 | ₹374 Cr | -43.15 | |
| Sep2024 | ₹659 Cr | 23.22 | |
| Jun2024 | ₹535 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 40.40 % |
| Y-o-Y | 16.59 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 16.16 % | 40.40 | |
| Dec2025 | 11.51 % | -17.84 | |
| Sep2025 | 14.01 % | 13.35 | |
| Jun2025 | 12.36 % | -10.82 | |
| Mar2025 | 13.86 % | 18.36 | |
| Dec2024 | 11.71 % | -45.59 | |
| Sep2024 | 21.52 % | 15.45 | |
| Jun2024 | 18.64 % | - | |
MANKIND PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 35.66 % |
| Y-o-Y | 31.67 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹13.43 | 35.66 | |
| Dec2025 | ₹9.9 | -20.10 | |
| Sep2025 | ₹12.39 | 16.67 | |
| Jun2025 | ₹10.62 | 4.12 | |
| Mar2025 | ₹10.2 | 10.63 | |
| Dec2024 | ₹9.22 | -43.47 | |
| Sep2024 | ₹16.31 | 21.81 | |
| Jun2024 | ₹13.39 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD